In line with these observations, MYH9 overexpression resulted in a significant reduction in GSK-3β expression in HNSCC cells, an effect that was largely counteracted by ACTN1 depletion (Fig. 5Q, Supplementary Fig. 9G). This evidence concerns the gene GSK3B and head and neck squamous cell carcinoma.